BeStock  
Stocks › Medical Devices › AXGN

AxoGen AXGN

US equityMarket cap rank #2355Medical Devices
$55.75 −$0.60 (-1.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.10 +0.63%
Open$55.71
Prev close$56.35
Day range$55.03 – $56.91
Volume876.1K
Market cap$3.33B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±15.1%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+36.9%
Worst reaction-23.2%

Stock move on the day after each report

-15.1%2023/Q4-10.4%2024/Q1+35.1%2024/Q2-13.4%2024/Q3+11.7%2024/Q4-23.2%2025/Q1+9.3%2025/Q2+23.1%2025/Q3-8.1%2025/Q4+6.6%2026/Q1+0.5%2026/Q2+31.5%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q328 Oct 2026Pre Market±22.9%+31.47%Bigger than priced
2026/Q229 Jul 2026Pre Market±15.7%+0.53%Within range
2026/Q128 Apr 2026Pre Market±15.4%+6.60%Within range
2025/Q424 Feb 2026Pre Market±15.7%-8.14%Within range
2025/Q329 Oct 2025Pre Market±15.4%+23.06%Bigger than priced
2025/Q25 Aug 2025Pre Market±26.4%+9.32%Within range
2025/Q18 May 2025Pre Market±16.2%-23.18%Bigger than priced
2024/Q425 Feb 2025Pre Market±19.8%+11.66%Within range
2024/Q37 Nov 2024Pre Market±23.3%-13.44%Within range
2024/Q28 Aug 2024Pre Market–+35.10%–
2024/Q12 May 2024Pre Market±14.5%-10.37%Within range
2023/Q45 Mar 2024Pre Market±14.9%-15.11%Bigger than priced
2023/Q37 Nov 2023Pre Market±32.7%+36.90%Bigger than priced
2023/Q27 Aug 2023None±17.0%-1.66%Within range
2023/Q19 May 2023Pre Market–-3.52%–
2022/Q414 Mar 2023Pre Market–+11.95%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$75.83M+26.2% YoY
Operating profit$955,000.00-50.1% YoY
Net profit$2.33M+229.7% YoY
Diluted EPS$0.04+300.0% YoY
Free cash flow$14.87M+995.0% YoY
Operating cash flow$16.54M

Revenue, last 8 quarters

$49.4MDec '24$48.6MMar '25$56.7MJun '25$60.1MSep '25$59.9MDec '25$61.5MMar '26$69.7MJun '26$75.8MSep '26

Net profit, last 8 quarters

$450.0KDec '24$-3.8MMar '25$579.0KJun '25$708.0KSep '25$-13.2MDec '25$-19.6MMar '26$-1.5MJun '26$2.3MSep '26

Profitability & balance sheet

Gross margin74.2%
Operating margin-5.2%
Net margin-12.0%
Return on equity-10.3%
Return on assets-8.3%
Return on invested capital-8.4%
Current ratio12.02
Liabilities / assets9.9%
Cash & investments$348.07M
Total debt$17.64M
Net cash (debt)$330.43M
Free cash flow / sales7.5%

Discussion

No comments yet — be the first to weigh in on AXGN.

Sign in to join the discussion.

Scroll to Top